{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:03:38Z","timestamp":1790291018813,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01512-x","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:45:01Z","timestamp":1773330301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical performance of ASCL1\/LHX8 DNA methylation on first-void urine to screen for cervical cancer"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1842-7478","authenticated-orcid":false,"given":"Severien","family":"Van Keer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianne","family":"van den Helder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7484-0956","authenticated-orcid":false,"given":"Laura","family":"T\u00e9blick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemie","family":"De Smet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Donders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Weyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Doyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke","family":"van Trommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantijne H.","family":"Mom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Verhoeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J. L. M.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Bleeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Cornelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2026-9790","authenticated-orcid":false,"given":"Koen","family":"Van de Vijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katty","family":"Delbecque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Lissenberg-Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0265-058X","authenticated-orcid":false,"given":"Alex","family":"Vorsters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2327-9839","authenticated-orcid":false,"given":"Renske D. M.","family":"Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"1512_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco, G. et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383, 524\u2013532 (2014).","journal-title":"Lancet"},{"key":"1512_CR2","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","volume":"30","author":"M Arbyn","year":"2012","unstructured":"Arbyn, M. et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 30, F88\u2013F99 (2012).","journal-title":"Vaccine"},{"key":"1512_CR3","doi-asserted-by":"publisher","first-page":"k4823","DOI":"10.1136\/bmj.k4823","volume":"363","author":"M Arbyn","year":"2018","unstructured":"Arbyn, M., Smith, S. B., Temin, S., Sultana, F. & Castle, P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. Bmj 363, k4823 (2018).","journal-title":"Bmj"},{"key":"1512_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41416-022-02094-w","volume":"128","author":"S Costa","year":"2023","unstructured":"Costa, S., Verberckmoes, B., Castle, P. E. & Arbyn, M. Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening. Br. J. Cancer 128, 805\u2013813 (2023).","journal-title":"Br. J. Cancer"},{"key":"1512_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/ijph.2022.1604284","volume":"67","author":"C Lefeuvre","year":"2022","unstructured":"Lefeuvre, C. et al. Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening. Int J. Public Health 67, 1604284 (2022).","journal-title":"Int J. Public Health"},{"key":"1512_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jinf.2015.05.001","volume":"71","author":"A Ducancelle","year":"2015","unstructured":"Ducancelle, A. et al. Home-based urinary HPV DNA testing in women who do not attend cervical cancer screening clinics. J. Infect. 71, 377\u2013384 (2015).","journal-title":"J. Infect."},{"key":"1512_CR7","doi-asserted-by":"publisher","first-page":"e041512","DOI":"10.1136\/bmjopen-2020-041512","volume":"11","author":"D Ornskov","year":"2021","unstructured":"Ornskov, D. et al. Clinical performance and acceptability of self-collected vaginal and urine samples compared with clinician-taken cervical samples for HPV testing among women referred for colposcopy. A cross-sectional study. BMJ Open 11, e041512 (2021).","journal-title":"BMJ Open"},{"key":"1512_CR8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jmoldx.2023.09.008","volume":"25","author":"A Latsuzbaia","year":"2023","unstructured":"Latsuzbaia, A. et al. Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol. J. Mol. Diagn. 25, 957\u2013966 (2023).","journal-title":"J. Mol. Diagn."},{"key":"1512_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2022.105271","volume":"155","author":"S Van Keer","year":"2022","unstructured":"Van Keer, S. et al. Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study. J. Clin. Virol. 155, 105271 (2022).","journal-title":"J. Clin. Virol."},{"key":"1512_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ygyno.2021.06.010","volume":"162","author":"S Van Keer","year":"2021","unstructured":"Van Keer, S. et al. Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol. Gynecol. Oncol. 162, 575\u2013583 (2021).","journal-title":"Gynecol. Oncol."},{"key":"1512_CR11","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3390\/v15091889","volume":"15","author":"M Martinelli","year":"2023","unstructured":"Martinelli, M. et al. Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy. Viruses 15, 1889 (2023).","journal-title":"Viruses"},{"key":"1512_CR12","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/1471-0528.17831","volume":"131","author":"JC Davies","year":"2024","unstructured":"Davies, J. C. et al. Urine high-risk human papillomavirus testing as an alternative to routine cervical screening: A comparative diagnostic accuracy study of two urine collection devices using a randomised study design trial. Bjog 131, 1456\u20131464 (2024).","journal-title":"Bjog"},{"key":"1512_CR13","doi-asserted-by":"publisher","first-page":"g6252","DOI":"10.1136\/bmj.g6252","volume":"349","author":"A Vorsters","year":"2014","unstructured":"Vorsters, A., Van Damme, P. & Clifford, G. Urine testing for HPV: rationale for using first void. BMJ 349, g6252 (2014).","journal-title":"BMJ"},{"key":"1512_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/cancers13030535","volume":"13","author":"AE Hentschel","year":"2021","unstructured":"Hentschel, A. E. et al. The Origin of Tumor DNA in Urine of Urogenital Cancer Patients: Local Shedding and Transrenal Excretion. Cancers (Basel) 13, 535 (2021).","journal-title":"Cancers (Basel)"},{"key":"1512_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/ijc.31391","volume":"143","author":"E Kellen","year":"2018","unstructured":"Kellen, E. et al. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program. Int J. Cancer 143, 861\u2013868 (2018).","journal-title":"Int J. Cancer"},{"key":"1512_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1470-2045(14)70019-1","volume":"15","author":"VM Verhoef","year":"2014","unstructured":"Verhoef, V. M. et al. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial. Lancet Oncol. 15, 315\u2013322 (2014).","journal-title":"Lancet Oncol."},{"key":"1512_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrc3728","volume":"14","author":"RD Steenbergen","year":"2014","unstructured":"Steenbergen, R. D., Snijders, P. J., Heideman, D. A. & Meijer, C. J. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat. Rev. Cancer 14, 395\u2013405 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"1512_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000450595","volume":"60","author":"AT Lorincz","year":"2016","unstructured":"Lorincz, A. T. Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer Prevention. Acta Cytol. 60, 501\u2013512 (2016).","journal-title":"Acta Cytol."},{"key":"1512_CR19","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41416-019-0593-4","volume":"121","author":"H Kelly","year":"2019","unstructured":"Kelly, H. et al. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis. Br. J. Cancer 121, 954\u2013965 (2019).","journal-title":"Br. J. Cancer"},{"key":"1512_CR20","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1158\/1078-0432.CCR-17-3615","volume":"24","author":"W Verlaat","year":"2018","unstructured":"Verlaat, W. et al. Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples. Clin. Cancer Res. 24, 3456\u20133464 (2018).","journal-title":"Clin. Cancer Res."},{"key":"1512_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41416-023-02277-z","volume":"129","author":"L Verhoef","year":"2023","unstructured":"Verhoef, L. et al. Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening. Br. J. Cancer 129, 104\u2013111 (2023).","journal-title":"Br. J. Cancer"},{"key":"1512_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ygyno.2014.08.003","volume":"135","author":"VM Verhoef","year":"2014","unstructured":"Verhoef, V. M. et al. Methylation marker analysis and HPV16\/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer. Gynecol. Oncol. 135, 58\u201363 (2014).","journal-title":"Gynecol. Oncol."},{"key":"1512_CR23","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1158\/1078-0432.CCR-21-3710","volume":"28","author":"R van den Helder","year":"2022","unstructured":"van den Helder, R. et al. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection. Clin. Cancer Res. 28, 2061\u20132068 (2022).","journal-title":"Clin. Cancer Res."},{"key":"1512_CR24","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1158\/1940-6207.CAPR-16-0138","volume":"9","author":"R Guerrero-Preston","year":"2016","unstructured":"Guerrero-Preston, R. et al. Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes. Cancer Prev. Res (Philos.) 9, 915\u2013924 (2016).","journal-title":"Cancer Prev. Res (Philos.)"},{"key":"1512_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87329-1","volume":"11","author":"S Van Keer","year":"2021","unstructured":"Van Keer, S. et al. Triage of human papillomavirus infected women by methylation analysis in first-void urine. Sci. Rep. 11, 7862 (2021).","journal-title":"Sci. Rep."},{"key":"1512_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.21037\/tcr.2017.01.41","volume":"6","author":"R Hoffstetter","year":"2017","unstructured":"Hoffstetter, R. et al. Evaluation of DNA methylation in promoter regions of SFRP4 and ZAR1 in urine and plasma of women with cervical lesions. Transl. Cancer Res. 6, 157\u2013168 (2017).","journal-title":"Transl. Cancer Res."},{"key":"1512_CR27","doi-asserted-by":"crossref","unstructured":"Schaafsma, M. et al. Recurrent cervical cancer detection using DNA methylation markers in self-collected samples from home. Int. J. Cancer, (2024).","DOI":"10.1002\/ijc.35143"},{"key":"1512_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39275-2","volume":"9","author":"BC Snoek","year":"2019","unstructured":"Snoek, B. C. et al. Cervical cancer detection by DNA methylation analysis in urine. Sci. Rep. 9, 3088 (2019).","journal-title":"Sci. Rep."},{"key":"1512_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2020.100193","volume":"9","author":"R van den Helder","year":"2020","unstructured":"van den Helder, R. et al. Methylation analysis in urine fractions for optimal CIN3 and cervical cancer detection. Papillomavirus Res. 9, 100193 (2020).","journal-title":"Papillomavirus Res."},{"key":"1512_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100528","volume":"37","author":"J de Waard","year":"2024","unstructured":"de Waard, J. et al. Methylation Analysis to Detect CIN3+ in High-Risk Human Papillomavirus-Positive Self-Samples From the Population-Based Cervical Cancer Screening Program. Mod. Pathol. 37, 100528 (2024).","journal-title":"Mod. Pathol."},{"key":"1512_CR31","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/ijc.32614","volume":"147","author":"FJ Vink","year":"2020","unstructured":"Vink, F. J. et al. FAM19A4\/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study. Int J. Cancer 147, 1215\u20131221 (2020).","journal-title":"Int J. Cancer"},{"key":"1512_CR32","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/ijc.29824","volume":"138","author":"R Luttmer","year":"2016","unstructured":"Luttmer, R. et al. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16\/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study). Int. J. Cancer 138, 992\u20131002 (2016).","journal-title":"Int. J. Cancer"},{"key":"1512_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ijc.33815","volume":"150","author":"C Banila","year":"2022","unstructured":"Banila, C. et al. Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study. Int. J. Cancer 150, 290\u2013302 (2022).","journal-title":"Int. J. Cancer"},{"key":"1512_CR34","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/ijc.31539","volume":"143","author":"LMA De Strooper","year":"2018","unstructured":"De Strooper, L. M. A. et al. Cervical cancer risk in HPV-positive women after a negative FAM19A4\/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up. Int. J. Cancer 143, 1541\u20131548 (2018).","journal-title":"Int. J. Cancer"},{"key":"1512_CR35","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ygyno.2019.06.002","volume":"154","author":"S Dick","year":"2019","unstructured":"Dick, S. et al. Long-term CIN3+ risk of HPV positive women after triage with FAM19A4\/miR124-2 methylation analysis. Gynecol. Oncol. 154, 368\u2013373 (2019).","journal-title":"Gynecol. Oncol."},{"key":"1512_CR36","doi-asserted-by":"publisher","first-page":"125 e121","DOI":"10.1016\/j.cmi.2020.03.018","volume":"27","author":"FJ Vink","year":"2021","unstructured":"Vink, F. J. et al. FAM19A4\/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort. Clin. Microbiol Infect. 27, 125 e121\u2013125 e126 (2021).","journal-title":"Clin. Microbiol Infect."},{"key":"1512_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ijc.34913","volume":"155","author":"C Gilham","year":"2024","unstructured":"Gilham, C. et al. Long-term prediction by DNA methylation of high-grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort. Int. J. Cancer 155, 81\u201392 (2024).","journal-title":"Int. J. Cancer"},{"key":"1512_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-024-00623-1","volume":"19","author":"EG Sumiec","year":"2024","unstructured":"Sumiec, E. G., Yim, Z. Y., Mohy-Eldin, H. & Nedjai, B. The current state of DNA methylation biomarkers in self-collected liquid biopsies for the early detection of cervical cancer: a literature review. Infect. Agent Cancer 19, 62 (2024).","journal-title":"Infect. Agent Cancer"},{"key":"1512_CR39","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.3390\/molecules26071989","volume":"26","author":"L T\u00e9blick","year":"2021","unstructured":"T\u00e9blick, L. et al. Impact of Collection Volume and DNA Extraction Method on the Detection of Biomarkers and HPV DNA in First-Void Urine. Molecules 26, 1989 (2021).","journal-title":"Molecules"},{"key":"1512_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70254","volume":"97","author":"S Van Keer","year":"2025","unstructured":"Van Keer, S. et al. Clinical and Analytical Evaluation of the Abbott Alinity m HR HPV Assay in a New Generation First-Void Urine Collector. J. Med. Virol. 97, e70254 (2025).","journal-title":"J. Med. Virol."},{"key":"1512_CR41","unstructured":"BE 71030031000; Biobank Antwerpen@UZA B-E, Belgian No. Access: (2), Last: (specify date of last access in the format: Month, DD, YYYY). [BIORESOURCE].)."},{"key":"1512_CR42","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.cmi.2021.04.031","volume":"27","author":"M Arbyn","year":"2021","unstructured":"Arbyn, M. et al. 2020 list of human papillomavirus assays suitable for primary cervical cancer screening. Clin. Microbiol Infect. 27, 1083\u20131095 (2021).","journal-title":"Clin. Microbiol Infect."},{"key":"1512_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12905-019-0743-0","volume":"19","author":"H Frayle","year":"2019","unstructured":"Frayle, H. et al. HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system. BMC Women\u2019s. Health 19, 47 (2019).","journal-title":"BMC Women\u2019s. Health"},{"key":"1512_CR44","doi-asserted-by":"publisher","first-page":"e01239","DOI":"10.1128\/JCM.01239-18","volume":"57","author":"M Saville","year":"2019","unstructured":"Saville, M. et al. Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening. J. Clin. Microbiol 57, e01239\u201318 (2019).","journal-title":"J. Clin. Microbiol"},{"key":"1512_CR45","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jcv.2018.08.006","volume":"107","author":"M Arbyn","year":"2018","unstructured":"Arbyn, M. et al. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples. J. Clin. Virol. 107, 52\u201356 (2018).","journal-title":"J. Clin. Virol."},{"key":"1512_CR46","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."},{"key":"1512_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01537-2","volume":"15","author":"S Salta","year":"2023","unstructured":"Salta, S., Lobo, J., Magalh\u00e3es, B., Henrique, R. & Jer\u00f3nimo, C. DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis. Clin. Epigenetics 15, 125 (2023).","journal-title":"Clin. Epigenetics"},{"key":"1512_CR48","unstructured":"Altman D. G. Practical statistics for medical research. Chapman & Hall\/CRC (1991)."},{"key":"1512_CR49","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ijc.33820","volume":"150","author":"L Verhoef","year":"2022","unstructured":"Verhoef, L. et al. Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort. Int. J. Cancer 150, 440\u2013449 (2022).","journal-title":"Int. J. Cancer"},{"key":"1512_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.111227","volume":"166","author":"AR Brentnall","year":"2024","unstructured":"Brentnall, A. R., Cuschieri, K., Sargent, A., Berkhof, J. & Rebolj, M. Staged design recommendations for validating relative sensitivity of self-sample human papillomavirus tests for cervical screening. J. Clin. Epidemiol. 166, 111227 (2024).","journal-title":"J. Clin. Epidemiol."},{"key":"1512_CR51","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2217\/epi-2019-0331","volume":"12","author":"S Dick","year":"2020","unstructured":"Dick, S. et al. Evaluation of six methylation markers derived from genome-wide screens for detection of cervical precancer and cancer. Epigenomics 12, 1569\u20131578 (2020).","journal-title":"Epigenomics"},{"key":"1512_CR52","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/S1470-2045(22)00294-7","volume":"23","author":"M Arbyn","year":"2022","unstructured":"Arbyn, M. et al. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis. Lancet Oncol. 23, 950\u2013960 (2022).","journal-title":"Lancet Oncol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01512-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01512-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01512-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:02:29Z","timestamp":1777334549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01512-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1512"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01512-x","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Alex Vorsters is co-founder and former board member of Novosanis, a spin-off company of the University of Antwerp, and was minority shareholder until January 2019. Alex Vorsters holds patents related to this work. The University of Antwerp obtained unrestricted educational grants from Becton Dickinson, Hologic, and Roche. Renske DM Steenbergen and Chris JLM Meijer are co-founders and minority shareholders of Self-Screen B.V. Self-screen B.V. holds patents related to this work, and develops, manufactures, and licenses high-risk HPV and methylation marker assays. Renske DM Steenbergen declares consultancy fees from AstraZeneca. Chris JLM Meijer is part-time CEO of Self-screen BV and declares consultancy fees from Qiagen and Asieris pharma\/Ismar Health care BV. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}